- Home
- HRL vs NBIX Comparison
HRL vs NBIX Comparison
Compare HRL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRL
- NBIX
- Stock Information
- Founded
- HRL 1891
- NBIX 1992
- Country
- HRL United States
- NBIX United States
- Employees
- HRL N/A
- NBIX N/A
- Industry
- HRL Meat/Poultry/Fish
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HRL Consumer Staples
- NBIX Health Care
- Exchange
- HRL Nasdaq
- NBIX Nasdaq
- Market Cap
- HRL 14.1B
- NBIX 14.4B
- IPO Year
- HRL N/A
- NBIX 1996
- Fundamental
- Price
- HRL $23.95
- NBIX $141.18
- Analyst Decision
- HRL Buy
- NBIX Strong Buy
- Analyst Count
- HRL 5
- NBIX 17
- Target Price
- HRL $30.80
- NBIX $164.94
- AVG Volume (30 Days)
- HRL 4.2M
- NBIX 846.8K
- Earning Date
- HRL 12-03-2025
- NBIX 10-28-2025
- Dividend Yield
- HRL 4.83%
- NBIX N/A
- EPS Growth
- HRL N/A
- NBIX 2.97
- EPS
- HRL 1.37
- NBIX 3.39
- Revenue
- HRL $12,058,590,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- HRL $2.92
- NBIX $20.79
- Revenue Next Year
- HRL $2.70
- NBIX $14.73
- P/E Ratio
- HRL $17.54
- NBIX $41.31
- Revenue Growth
- HRL 0.65
- NBIX 18.42
- 52 Week Low
- HRL $23.13
- NBIX $84.23
- 52 Week High
- HRL $33.80
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- HRL 39.25
- NBIX 56.17
- Support Level
- HRL $23.13
- NBIX $136.71
- Resistance Level
- HRL $24.12
- NBIX $140.73
- Average True Range (ATR)
- HRL 0.38
- NBIX 3.35
- MACD
- HRL 0.09
- NBIX -0.11
- Stochastic Oscillator
- HRL 45.52
- NBIX 79.87
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US food service (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.